Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110015 · ClinicalTrials.gov registry record
Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis
A clinical trial, sponsored by New York City Health and Hospitals Corporation.
- Terminated
- Registry status
- 120
- Enrollment target
NCT04110015: Clinical Trial study, sponsored by New York City Health and Hospitals Corporation.
NCT04110015 is a clinical trial that was terminated before completion, run by New York City Health and Hospitals Corporation. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04110015 was terminated before completion, sponsored by New York City Health and Hospitals Corporation.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
1. To evaluate the accuracy of virtual visual field (VVF) headsets equipped the standard visual field software in its ability to assess visual function in various retinal, glaucoma and neuro-ophthalmic disorders by comparing retinal fundus and optic nerve images, optical coherence tomography and neuroimages to the VVF produced. 2. To test the null hypothesis that VVF testing compares favorably to the gold standard, Humphrey visual field (HVF) by comparing testing time, mean sensitivity, markers of reliability including false positives and negatives and fixation losses and global indices such as mean deviation and pattern standard deviation.
Primary Outcome
Gray scale pattern will reveal areas of vision loss or visual depression; this will have a numerical total deviation plot giving numbers in decibels of the points in the visual field of depressed or lost points of vision. Global indices also will be recorded; these give numerical quantification in decibel units of visual field loss. and include: mean deviation - the average of all decreased perception, pattern deviation which highlights localized losses and pattern standard deviation which quant
Interventions
- DEVICE virtual visual field
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-08-23 |
Why NCT04110015 stopped before completion
NCT04110015 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which virtual visual field is the first listed.
NCT04110015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04110015 about?
NCT04110015 is a clinical study titled "Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis". 1. To evaluate the accuracy of virtual visual field (VVF) headsets equipped the standard visual field software in its ability to assess visual function in various retinal, glaucoma and neuro-ophthalmic disorders by comparing retinal fundus and optic nerve images, optical coherence tomography and neu...
What is the current status of trial NCT04110015?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2020-10-01. Estimated completion is 2021-08-23.
What interventions are being tested in trial NCT04110015?
The interventions under investigation include: virtual visual field (DEVICE).
Who is sponsoring clinical trial NCT04110015?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI